leadf
logo-loader
viewOpyl Ltd

ShareRoot notches second Australian deal, lifts financials

ShareRoot CEO Noah Abelson-Girdler says the company's second MediaConsent deal in Australia with Neuroscience Trials Australia shows the potential of further deals for its data regulation platform product.

Abelson-Girdler also says the company has slowed its cash burn and lifted revenue.

Quick facts: Opyl Ltd

Price: 0.135 AUD

ASX:OPL
Market: ASX
Market Cap: $4.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Opyl Ltd named herein, including the promotion by the Company of Opyl Ltd in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Opyl Ltd CEO says successful COVID-19 data trial is validation of its platform

Opyl Ltd's (ASX:OPL) Michelle Gallaher updates Proactive's Andrew Scott on developments with their clinical predictor and clinical trials recruitment platforms. The company's developed software that uses artificial intelligence (AI) to make a probability of success prediction on the likelihood...

1 week, 4 days ago

2 min read